How brain processes are rewired in Parkinson's disease

Published Date: 02 Mar 2023

Researchers from the University of Queensland have confirmed that genes associated with the risk of Parkinson's disease also contribute to the production of cellular debris in the brain.

Read Full News

Latest News

‘Good First Try’: In Vivo CAR T for Neuro Autoimmune Disease

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Which Therapies Offer the Lowest Relapse Rates in Early MS?

Patients with MS starting B-cell therapies had fewer relapses and less T2 lesion growth, but no measurable difference in disability after 2 years.

AbbVie's Menstrual Migraine Treatment Meets Late-stage Study Goal

AbbVie said on Thursday its migraine treatment had in ⁠a late-stage study reduced the migraine days associated with the ⁠menstrual period.

US FDA Pauses New Enrollment in Biohaven's Epilepsy Drug Trials

Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials ⁠of its experimental epilepsy drug after rodent...

Tylenol Use in Pregnancy May Be Linked With Uterus, Ovary Changes in Daughters

Female reproductive organ development may be impacted by a mother's use during pregnancy of Tylenol or its generic versions, according to researchers who emphasize that...

Ionis Pharma Prices First FDA-approved Treatment for Alexander Disease At $285,000 Per Dose

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Todays Updates

Annual Cancer Report Highlights Advances, Funding Threats

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Does Telenursing Improve QOL in Breast Cancer?

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

Long-Term Results Favor Acalabrutinib Combo in MCL

The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.

Latest News

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Patients with MS starting B-cell therapies had fewer relapses and less T2 lesion growth, but no measurable difference in disability after 2 years.

AbbVie said on Thursday its migraine treatment had in ⁠a late-stage study reduced the migraine days associated with the ⁠menstrual period.

Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials ⁠of its experimental epilepsy drug after rodent...

Female reproductive organ development may be impacted by a mother's use during pregnancy of Tylenol or its generic versions, according to researchers who emphasize that...

Ionis Pharmaceuticals said on Friday it would price its newly approved therapy ⁠to treat Alexander disease at $285,000 per dose, a day after the U.S. FDA cleared the...

News All Time

What New Research Shows About Prenatal Pesticide Exposure and Autism Traits

— Chlorpyrifos and other organophosphate insecticides had no association at low exposure levels

Young Girl Dies From Rare Brain-Eating Amoeba

Louisiana experienced its first confirmed Naegleria fowleri infection since 2013

The New Standard in Multiple Sclerosis: Integrating Evolving Treatment Evidence and Biomarkers to Target Progression

The New Standard in Multiple Sclerosis: Integrating Evolving Treatment Evidence and Biomarkers to Target Progression

Navigating Diagnostic Complexity in Leptomeningeal Metastases: Real-World Case Challenges in Timely Diagnosis of Leptomeningeal Metastases

Navigating Diagnostic Complexity in Leptomeningeal Metastases: Real-World Case Challenges in Timely Diagnosis of Leptomeningeal Metastases

Dravet Syndrome Clinical Pearls: Uncovering Disease Impact and Partnering With Patients and Caregivers to Individualize Treatment Plans

Dravet Syndrome Clinical Pearls: Uncovering Disease Impact and Partnering With Patients and Caregivers to Individualize Treatment Plans

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Leptomeningeal Metastases: Early Recognition, Diagnosis, and Multidisciplinary Care

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Decoding Leptomeningeal Metastases: Strategies for Early Detection and Accurate Diagnosis

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Inherited Alzheimer's risk didn't differ between superagers and cognitively average older adults

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Health news and commentary gathered by MedPage Today staff

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

Good things come to those who wait -- and to those who don't wait

FDA Approves Tylenol With Naproxen Combination

First OTC fixed-dose combination product to pair acetaminophen with naproxen sodium

FDA Panel Finds a Peptide It Doesn't Like

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

MRI uncovers neurocysticercosis in a 52-year-old woman

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older

FDA Scientists Raise Questions About Duchenne Drug

Agency says deramiocel did not meet phase III trial endpoints, contrary to reported data

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

News and commentary from the world of neurology and neuroscience

Recommended News For You

Conditional EU Nod for Weekly Pill in Pediatric Glioma

EBCC: European Breast Cancer Conference

Skipping Lymph Node Biopsy Gains Ground in Breast Cancer

Cancerous breast tissue glows in new AI-enhanced MRI images

Poor agreement between diagnostic tests for breast cancer-related lymphedema

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.

Recommended Articles For You

Fc Receptor Mediated Pharmacology of Therapeutic Antibodies 

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy 

Bone Marrow Regenerative Capacity and Hematologic Recovery 

What You Need To Know About Secondary Polycythemia: Treatment & Symptoms 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Why preventive mastectomy isn't offered to everyone at risk

2.

Low Income, Education Tied to Depression in Older Adults

3.

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

4.

A new theranostic drug targets different cancer types.

5.

Effective Intralesional Melanoma Therapy May Involve Systemic Effects.

1.

Drug Safety Monitoring of Delayed Hematologic Effects After Prolonged Medication Exposure

2.

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy

3.

Patient Management for Bone Marrow Functional Recovery Pathways

4.

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options

5.

Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Nutrition During Cancer Treatment

2.

Navigating the Complexities of Ph Negative ALL - Part V

3.

Immunotherapy: A New Era in Cancer Treatment

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

Innovations in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot